Determining risk of vertebral osteoporosis in men

Validation of the male osteoporosis risk estimation score

Angela Shepherd, Alvah R. Cass, Laura Ray

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Vertebral fracture, one of the most frequent osteoporotic fractures in both sexes, is a powerful indicator of future osteoporotic fractures. Vertebral fractures are associated with increased mortality and decreased quality of life. Osteoporosis is a major predictor of low-trauma fracture. The Male Osteoporosis Risk Estimation Score (MORES), a clinical prediction tool that uses age, weight, and a history of chronic obstructive pulmonary disorder, was developed and validated previously to identify men at risk for hip osteoporosis who might benefit from bone densitometry. This study evaluated the effectiveness of the MORES to identify men at risk of lumbar osteoporosis. Methods: US population data from the National Health and Nutrition Examination Survey (NHANES, 1999-2004) were used to test the validity of the MORES to identify men at risk of lumbar osteoporosis. Results: The MORES value was compared with vertebral done densitometry (DXA) scores for men 50 years of age and older. The sensitivity was 0.582 (95% CI, 0.460-0.694) and specificity was 0.652 (95% CI, 0.627- 0.676). Comparing universal DXA screening in 50-year-old men, the number needed to screen (NNS) to prevent one case of vertebral fracture would be reduced from 9418 to 3641 by prescreening with the MORES. In 70-year-old men, the MORES reduced the NNS from 4987 with universal screening to 3583. Conclusion: This analysis validated the MORES as a clinical tool to identify men at risk for lumbar osteoporosis. Compared with universal screening, the MORES was able to reduce the NNS to prevent one additional vertebral fracture across all age groups except in men 85 to 89 years of age. The magnitude of the NNS to prevent one additional vertebral fracture does not support using the MORES to screen solely for osteoporosis of the lumbar spine.

Original languageEnglish (US)
Pages (from-to)186-194
Number of pages9
JournalJournal of the American Board of Family Medicine
Volume23
Issue number2
DOIs
StatePublished - Mar 2010

Fingerprint

Osteoporosis
Osteoporotic Fractures
Densitometry
Nutrition Surveys
Hip
Spine
Age Groups
Quality of Life

Keywords

  • Men
  • Osteoporosis
  • Osteoporosis risk estimates
  • Validation

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Family Practice

Cite this

Determining risk of vertebral osteoporosis in men : Validation of the male osteoporosis risk estimation score. / Shepherd, Angela; Cass, Alvah R.; Ray, Laura.

In: Journal of the American Board of Family Medicine, Vol. 23, No. 2, 03.2010, p. 186-194.

Research output: Contribution to journalArticle

@article{93deba57376d4324a7cde7e6443cd235,
title = "Determining risk of vertebral osteoporosis in men: Validation of the male osteoporosis risk estimation score",
abstract = "Background: Vertebral fracture, one of the most frequent osteoporotic fractures in both sexes, is a powerful indicator of future osteoporotic fractures. Vertebral fractures are associated with increased mortality and decreased quality of life. Osteoporosis is a major predictor of low-trauma fracture. The Male Osteoporosis Risk Estimation Score (MORES), a clinical prediction tool that uses age, weight, and a history of chronic obstructive pulmonary disorder, was developed and validated previously to identify men at risk for hip osteoporosis who might benefit from bone densitometry. This study evaluated the effectiveness of the MORES to identify men at risk of lumbar osteoporosis. Methods: US population data from the National Health and Nutrition Examination Survey (NHANES, 1999-2004) were used to test the validity of the MORES to identify men at risk of lumbar osteoporosis. Results: The MORES value was compared with vertebral done densitometry (DXA) scores for men 50 years of age and older. The sensitivity was 0.582 (95{\%} CI, 0.460-0.694) and specificity was 0.652 (95{\%} CI, 0.627- 0.676). Comparing universal DXA screening in 50-year-old men, the number needed to screen (NNS) to prevent one case of vertebral fracture would be reduced from 9418 to 3641 by prescreening with the MORES. In 70-year-old men, the MORES reduced the NNS from 4987 with universal screening to 3583. Conclusion: This analysis validated the MORES as a clinical tool to identify men at risk for lumbar osteoporosis. Compared with universal screening, the MORES was able to reduce the NNS to prevent one additional vertebral fracture across all age groups except in men 85 to 89 years of age. The magnitude of the NNS to prevent one additional vertebral fracture does not support using the MORES to screen solely for osteoporosis of the lumbar spine.",
keywords = "Men, Osteoporosis, Osteoporosis risk estimates, Validation",
author = "Angela Shepherd and Cass, {Alvah R.} and Laura Ray",
year = "2010",
month = "3",
doi = "10.3122/jabfm.2010.02.090027",
language = "English (US)",
volume = "23",
pages = "186--194",
journal = "Journal of the American Board of Family Medicine",
issn = "1557-2625",
publisher = "American Board of Family Medicine",
number = "2",

}

TY - JOUR

T1 - Determining risk of vertebral osteoporosis in men

T2 - Validation of the male osteoporosis risk estimation score

AU - Shepherd, Angela

AU - Cass, Alvah R.

AU - Ray, Laura

PY - 2010/3

Y1 - 2010/3

N2 - Background: Vertebral fracture, one of the most frequent osteoporotic fractures in both sexes, is a powerful indicator of future osteoporotic fractures. Vertebral fractures are associated with increased mortality and decreased quality of life. Osteoporosis is a major predictor of low-trauma fracture. The Male Osteoporosis Risk Estimation Score (MORES), a clinical prediction tool that uses age, weight, and a history of chronic obstructive pulmonary disorder, was developed and validated previously to identify men at risk for hip osteoporosis who might benefit from bone densitometry. This study evaluated the effectiveness of the MORES to identify men at risk of lumbar osteoporosis. Methods: US population data from the National Health and Nutrition Examination Survey (NHANES, 1999-2004) were used to test the validity of the MORES to identify men at risk of lumbar osteoporosis. Results: The MORES value was compared with vertebral done densitometry (DXA) scores for men 50 years of age and older. The sensitivity was 0.582 (95% CI, 0.460-0.694) and specificity was 0.652 (95% CI, 0.627- 0.676). Comparing universal DXA screening in 50-year-old men, the number needed to screen (NNS) to prevent one case of vertebral fracture would be reduced from 9418 to 3641 by prescreening with the MORES. In 70-year-old men, the MORES reduced the NNS from 4987 with universal screening to 3583. Conclusion: This analysis validated the MORES as a clinical tool to identify men at risk for lumbar osteoporosis. Compared with universal screening, the MORES was able to reduce the NNS to prevent one additional vertebral fracture across all age groups except in men 85 to 89 years of age. The magnitude of the NNS to prevent one additional vertebral fracture does not support using the MORES to screen solely for osteoporosis of the lumbar spine.

AB - Background: Vertebral fracture, one of the most frequent osteoporotic fractures in both sexes, is a powerful indicator of future osteoporotic fractures. Vertebral fractures are associated with increased mortality and decreased quality of life. Osteoporosis is a major predictor of low-trauma fracture. The Male Osteoporosis Risk Estimation Score (MORES), a clinical prediction tool that uses age, weight, and a history of chronic obstructive pulmonary disorder, was developed and validated previously to identify men at risk for hip osteoporosis who might benefit from bone densitometry. This study evaluated the effectiveness of the MORES to identify men at risk of lumbar osteoporosis. Methods: US population data from the National Health and Nutrition Examination Survey (NHANES, 1999-2004) were used to test the validity of the MORES to identify men at risk of lumbar osteoporosis. Results: The MORES value was compared with vertebral done densitometry (DXA) scores for men 50 years of age and older. The sensitivity was 0.582 (95% CI, 0.460-0.694) and specificity was 0.652 (95% CI, 0.627- 0.676). Comparing universal DXA screening in 50-year-old men, the number needed to screen (NNS) to prevent one case of vertebral fracture would be reduced from 9418 to 3641 by prescreening with the MORES. In 70-year-old men, the MORES reduced the NNS from 4987 with universal screening to 3583. Conclusion: This analysis validated the MORES as a clinical tool to identify men at risk for lumbar osteoporosis. Compared with universal screening, the MORES was able to reduce the NNS to prevent one additional vertebral fracture across all age groups except in men 85 to 89 years of age. The magnitude of the NNS to prevent one additional vertebral fracture does not support using the MORES to screen solely for osteoporosis of the lumbar spine.

KW - Men

KW - Osteoporosis

KW - Osteoporosis risk estimates

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=77949524778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949524778&partnerID=8YFLogxK

U2 - 10.3122/jabfm.2010.02.090027

DO - 10.3122/jabfm.2010.02.090027

M3 - Article

VL - 23

SP - 186

EP - 194

JO - Journal of the American Board of Family Medicine

JF - Journal of the American Board of Family Medicine

SN - 1557-2625

IS - 2

ER -